Tag Archives: bad ad

Happy Anniversary for FDA Bad Ad

Author:

In November 2010 we reported on the FDA’s Bad Ad Program, which asks physicians to anonymously report misleading advertising and off-label promotion by pharmaceutical sales representatives. Last March, Doctor Directory, a leading market service company for the healthcare industry, conducted a survey to measure physicians’ attitudes toward the initiative. 90% of over 1,000 practicing physicians said that they would be at least “somewhat likely” to report questionable behavior. Now, just in time for the 1st anniversary of the Bad Ad Program, the FDA has released their results of the measure thus far. Continue reading

Reporting and Abuse of FDA Bad Ad: Survey of 1000 Doctors

Author:

Back in November, we discussed the FDA’s Bad Ad Program, which asks physicians to anonymously report misleading advertising and off-label promotion by pharmaceutical sales representatives.

Now, ten months after the launch of the Bad Ad Program, Doctor Directory, a leading market service company for the healthcare industry, has conducted a survey of physician’s attitudes toward the initiative. Continue reading

The Good, the Bad, and the Ugly – FDA Wants Your Help to Stop Bad Drug Ads!

Author: Elsa Abruzzo

Unless you’ve been living under a rock or worse, have no internet access, it is clear that with respect to the “Good”—promotional practices that is—FDA has provided ample guidance to industry in order to educate us on the rights and wrongs.  They have even provided examples to help us deal with some of the potential gray areas.   My last blog post touched on FDA’s “Presenting Risk Information in Prescription and Drug and Medical Device Promotion” issued May 2009.  Yet, this only begins to scratch the “guidance” surface.  There are many more great resources from FDA, including a Division of Drug Marketing, Advertising, and Communications (DDMAC) link that whisks you off into a magical time portal of labeling and promotions industry guidances going back to 1997.   This is the friendly, gentler side of FDA…right? Continue reading